These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 10644434)

  • 1. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.
    Wagner T; Stoppa-Lyonnet D; Fleischmann E; Muhr D; Pagès S; Sandberg T; Caux V; Moeslinger R; Langbauer G; Borg A; Oefner P
    Genomics; 1999 Dec; 62(3):369-76. PubMed ID: 10644434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
    Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
    Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of specific BRCA1 and BRCA2 variants by DHPLC.
    Gross E; Arnold N; Pfeifer K; Bandick K; Kiechle M
    Hum Mutat; 2000 Oct; 16(4):345-53. PubMed ID: 11013445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for BRCA1 mutations: a cost-effectiveness analysis.
    Sevilla C; Moatti JP; Julian-Reynier C; Eisinger F; Stoppa-Lyonnet D; Bressac-de Paillerets B; Sobol H
    Eur J Hum Genet; 2002 Oct; 10(10):599-606. PubMed ID: 12357330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
    Meyer P; Voigtlaender T; Bartram CR; Klaes R
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers.
    Arnold N; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Kiechle M
    Hum Mutat; 1999; 14(4):333-9. PubMed ID: 10502781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
    van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
    Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
    Andrulis IL; Anton-Culver H; Beck J; Bove B; Boyd J; Buys S; Godwin AK; Hopper JL; Li F; Neuhausen SL; Ozcelik H; Peel D; Santella RM; Southey MC; van Orsouw NJ; Venter DJ; Vijg J; Whittemore AS;
    Hum Mutat; 2002 Jul; 20(1):65-73. PubMed ID: 12112659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening of the BRCA1 gene in Slovak patients.
    Tomka M; Sedlakova O; Reinerova M; Veselovska Z; Stevurková V; Bartosová Z; Zajac V
    Neoplasma; 2001; 48(6):451-5. PubMed ID: 11949836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.
    De Benedetti VM; Radice P; Pasini B; Stagi L; Pensotti V; Mondini P; Manoukian S; Conti A; Spatti G; Rilke F; Pierotti MA
    Hum Mutat; 1998; 12(3):215. PubMed ID: 10660329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland.
    Perkowska M; BroZek I; Wysocka B; Haraldsson K; Sandberg T; Johansson U; Sellberg G; Borg A; Limon J
    Hum Mutat; 2003 May; 21(5):553-4. PubMed ID: 12673801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
    Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations of BRCA1 and BRCA2 in Korean breast and/or ovarian cancer families.
    Kang HC; Kim IJ; Park JH; Kwon HJ; Won YJ; Heo SC; Lee SY; Kim KH; Shin Y; Noh DY; Yang DH; Choe KJ; Lee BH; King SB; Park JG
    Hum Mutat; 2002 Sep; 20(3):235. PubMed ID: 12204006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
    Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
    Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutations in a South American population.
    Jara L; Ampuero S; Santibáñez E; Seccia L; Rodríguez J; Bustamante M; Martínez V; Catenaccio A; Lay-Son G; Blanco R; Reyes JM
    Cancer Genet Cytogenet; 2006 Apr; 166(1):36-45. PubMed ID: 16616110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
    Andersen TI; Eiken HG; Couch F; Kaada G; Skrede M; Johnsen H; Aloysius TA; Tveit KM; Tranebjaerg L; Dørum A; Møller P; Weber BL; Børresen-Dale AL
    Hum Mutat; 1998; 11(2):166-74. PubMed ID: 9482581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.